Dissolved and financials
CVR: 37446939
DKK 62,291
Gross profit
Net result: DKK -39,817
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 14 February 2019
CVR · view overview
0 employees
CVR · 2017
Director role ended: Kristian Kongensholm Husted
CVR · 14/02/2019
View the full event history
4 IBD IVS was a Danish company of the type Iværksætterselskab based in Hvide Sande, founded in 2016. The company has been dissolved on 14 February 2019. The company was registered under the industry Virksomhedsrådgivning og anden rådgivning om driftsledelse. The company has 0 employees (2017). In 2017, the company reported a gross profit of DKK 62,291 and a net result of DKK -39,817 compared with DKK 102,817 the year before. Equity in the 2017 report amounted to DKK 11,301.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 201701/01/2017 – 31/12/2017 | 62 t. | -40 t. | 17 t. | 11 t. | 1 | |
| 201610/02/2016 – 31/12/2016 | 365 t. | 103 t. | 219 t. | 103 t. | 1 |
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningNo. 4 IBD IVS is registered in the Danish CVR register with the status Dissolved and ceased on 14 February 2019.
The CVR number of 4 IBD IVS is 37446939.
In 2017, 4 IBD IVS reported a gross profit of DKK 62,291.
4 IBD IVS had 0 employees in 2017 according to the Danish CVR register.
4 IBD IVS was founded on 10 February 2016.
4 IBD IVS was registered under the industry Virksomhedsrådgivning og anden rådgivning om driftsledelse (industry code 702200).
As of February 14, 2019, Kristian Kongensholm Husted has stepped down as liquidator of 4 IBD IVS.
On February 14, 2019, 4 IBD IVS exited liquidation.
4 IBD IVS was dissolved on February 14, 2019.
As of October 15, 2018, Kristian Kongensholm Husted is registered as liquidator of 4 IBD IVS.
As of October 15, 2018, Kristian Kongensholm Husted has stepped down as adm. dir. of 4 IBD IVS.
On October 15, 2018, 4 IBD IVS entered liquidation.
4 IBD IVS has published its annual report for 2017. Gross profit came to DKK 62,291, and the net result was DKK -39,817.
4 IBD IVS has published its interim report for the period February 10, 2016 to December 31, 2016.
As of February 10, 2016, Kristian Kongensholm Husted is registered as adm. dir. of 4 IBD IVS.
4 IBD IVS was founded on February 10, 2016.
